Login
← Go Back
Supriya Lifescience
SUPRIYA · Pharma > Pharmaceuticals & Drugs · Chairman: Satish Waman Wagh · MD: Satish Waman Wagh · Listing date: Dec. 29, 2021
Stock Price vs Company Growth
1d
3.3%
1w
3.8%
1m
34.2%
3m
57.9%
6m
24.3%
1y
35.2%
all
15.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 917 3.3%
546
1,086
Company Overview
Sales
828 Cr
Growth: 12.1%
Profit after Tax
209 Cr
Growth: 12.9%
Small Cap
7,377 Cr
P/E: 35.3x
Industry P/E: 31.3x
Fundamentals
Sales (Cr) ₹ 828
Growth 12.1%
EBITDA 35.5%
P/S 8.9x
Dividend 0.2%
P/E 35.3x
Book Value ₹ 2
PEG Ratio 2.9x
ROE 999.0%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.
Belongs to (12 Indices) view more
Investors (5)
jyotsana
rajeev4
shivani....
Followers (1)
varsha96